Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Nov 28, 2023 3:34pm
116 Views
Post# 35757063

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....LOL... yeah, and just what do you think will happen once they have a functional cure for Type 1 diabetes also..??  

How long has CRSP been around... is it ten years... maybe a bit less...  how long has ONCY been saying, 24 or is it 25... a quarter of the century being "on the cusp", must be another world record.

If the technology here was undeniably great, they would already have been bought... ONCY is floundering right now... Do we even know what the phase III for Panc will look like... 

If they don't even have a protocol ready, then they are still years, YEARS away from approval... The only partnership they have is with Adlai Nortye... who have completed their bridging trial and are so raring to go, they removed all reference to ONCY from their website... Matt sure has a great knack of finding partners

Abandoned by Pfizer back in the day
Phase II trials with Celgene spirited away with no comment
a Failed phase III H&N trial
Adlai Nortye who no longer appear to have any interest.

and now we have PanCan who for perfectly valid reasons (of course), decided to abandon inclusion of Pela in their trials...  woweee... you're onto a winner here Azzak... can't wait to see the stock price appreciation when they partner with McDonalds... safe and well tolerated... LOL too funny, too funny
.
Heaven knows you are so lost here... day after day, nothing but silence and hopium.

<< Previous
Bullboard Posts
Next >>